Global Rapid Diagnostic Testing for Influenza Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.
LPI (LP Information)' newest research report, the “Rapid Diagnostic Testing for Influenza Industry Forecast” looks at past sales and reviews total world Rapid Diagnostic Testing for Influenza sales in 2022, providing a comprehensive analysis by region and market sector of projected Rapid Diagnostic Testing for Influenza sales for 2023 through 2029. With Rapid Diagnostic Testing for Influenza sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rapid Diagnostic Testing for Influenza industry.
This Insight Report provides a comprehensive analysis of the global Rapid Diagnostic Testing for Influenza landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rapid Diagnostic Testing for Influenza portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rapid Diagnostic Testing for Influenza market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rapid Diagnostic Testing for Influenza and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rapid Diagnostic Testing for Influenza.
The global Rapid Diagnostic Testing for Influenza market size is projected to grow from US$ 1241.5 million in 2022 to US$ 1549.4 million in 2029; it is expected to grow at a CAGR of 3.2% from 2023 to 2029.
Americas is the largest Rapid Influenza Diagnostic Test (RIDT) market with about 58% market share. Europe is follower, accounting for about 27% market share.
The key players are BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscien?
This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Diagnostic Testing for Influenza market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.
LPI (LP Information)' newest research report, the “Rapid Diagnostic Testing for Influenza Industry Forecast” looks at past sales and reviews total world Rapid Diagnostic Testing for Influenza sales in 2022, providing a comprehensive analysis by region and market sector of projected Rapid Diagnostic Testing for Influenza sales for 2023 through 2029. With Rapid Diagnostic Testing for Influenza sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rapid Diagnostic Testing for Influenza industry.
This Insight Report provides a comprehensive analysis of the global Rapid Diagnostic Testing for Influenza landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rapid Diagnostic Testing for Influenza portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rapid Diagnostic Testing for Influenza market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rapid Diagnostic Testing for Influenza and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rapid Diagnostic Testing for Influenza.
The global Rapid Diagnostic Testing for Influenza market size is projected to grow from US$ 1241.5 million in 2022 to US$ 1549.4 million in 2029; it is expected to grow at a CAGR of 3.2% from 2023 to 2029.
Americas is the largest Rapid Influenza Diagnostic Test (RIDT) market with about 58% market share. Europe is follower, accounting for about 27% market share.
The key players are BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscien?
This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Diagnostic Testing for Influenza market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Digital RIDTs
- Conventional RIDT
- Hospitals
- POCT
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BD
- Abbot (Alere)
- Quidel
- Roche
- Thermo Fisher Scientific
- Meridian Bioscience
- Analytik Jena
- Princeton BioMeditech Corporation
- BioMerieux
- Sekisui Diagnostics
- Response Biomedical
- SA Scientific
- DiaSorin (Focus Diagnostics)
- Wondfo
- Beijing Wantai Biological Pharmacy
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rapid Diagnostic Testing for Influenza Market Size 2018-2029
2.1.2 Rapid Diagnostic Testing for Influenza Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Rapid Diagnostic Testing for Influenza Segment by Type
2.2.1 Digital RIDTs
2.2.2 Conventional RIDT
2.3 Rapid Diagnostic Testing for Influenza Market Size by Type
2.3.1 Rapid Diagnostic Testing for Influenza Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
2.4 Rapid Diagnostic Testing for Influenza Segment by Application
2.4.1 Hospitals
2.4.2 POCT
2.4.3 Others
2.5 Rapid Diagnostic Testing for Influenza Market Size by Application
2.5.1 Rapid Diagnostic Testing for Influenza Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
3 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET SIZE BY PLAYER
3.1 Rapid Diagnostic Testing for Influenza Market Size Market Share by Players
3.1.1 Global Rapid Diagnostic Testing for Influenza Revenue by Players (2018-2023)
3.1.2 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Players (2018-2023)
3.2 Global Rapid Diagnostic Testing for Influenza Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RAPID DIAGNOSTIC TESTING FOR INFLUENZA BY REGIONS
4.1 Rapid Diagnostic Testing for Influenza Market Size by Regions (2018-2023)
4.2 Americas Rapid Diagnostic Testing for Influenza Market Size Growth (2018-2023)
4.3 APAC Rapid Diagnostic Testing for Influenza Market Size Growth (2018-2023)
4.4 Europe Rapid Diagnostic Testing for Influenza Market Size Growth (2018-2023)
4.5 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Rapid Diagnostic Testing for Influenza Market Size by Country (2018-2023)
5.2 Americas Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023)
5.3 Americas Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rapid Diagnostic Testing for Influenza Market Size by Region (2018-2023)
6.2 APAC Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023)
6.3 APAC Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Rapid Diagnostic Testing for Influenza by Country (2018-2023)
7.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023)
7.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rapid Diagnostic Testing for Influenza by Region (2018-2023)
8.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023)
8.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET FORECAST
10.1 Global Rapid Diagnostic Testing for Influenza Forecast by Regions (2024-2029)
10.1.1 Global Rapid Diagnostic Testing for Influenza Forecast by Regions (2024-2029)
10.1.2 Americas Rapid Diagnostic Testing for Influenza Forecast
10.1.3 APAC Rapid Diagnostic Testing for Influenza Forecast
10.1.4 Europe Rapid Diagnostic Testing for Influenza Forecast
10.1.5 Middle East & Africa Rapid Diagnostic Testing for Influenza Forecast
10.2 Americas Rapid Diagnostic Testing for Influenza Forecast by Country (2024-2029)
10.2.1 United States Rapid Diagnostic Testing for Influenza Market Forecast
10.2.2 Canada Rapid Diagnostic Testing for Influenza Market Forecast
10.2.3 Mexico Rapid Diagnostic Testing for Influenza Market Forecast
10.2.4 Brazil Rapid Diagnostic Testing for Influenza Market Forecast
10.3 APAC Rapid Diagnostic Testing for Influenza Forecast by Region (2024-2029)
10.3.1 China Rapid Diagnostic Testing for Influenza Market Forecast
10.3.2 Japan Rapid Diagnostic Testing for Influenza Market Forecast
10.3.3 Korea Rapid Diagnostic Testing for Influenza Market Forecast
10.3.4 Southeast Asia Rapid Diagnostic Testing for Influenza Market Forecast
10.3.5 India Rapid Diagnostic Testing for Influenza Market Forecast
10.3.6 Australia Rapid Diagnostic Testing for Influenza Market Forecast
10.4 Europe Rapid Diagnostic Testing for Influenza Forecast by Country (2024-2029)
10.4.1 Germany Rapid Diagnostic Testing for Influenza Market Forecast
10.4.2 France Rapid Diagnostic Testing for Influenza Market Forecast
10.4.3 UK Rapid Diagnostic Testing for Influenza Market Forecast
10.4.4 Italy Rapid Diagnostic Testing for Influenza Market Forecast
10.4.5 Russia Rapid Diagnostic Testing for Influenza Market Forecast
10.5 Middle East & Africa Rapid Diagnostic Testing for Influenza Forecast by Region (2024-2029)
10.5.1 Egypt Rapid Diagnostic Testing for Influenza Market Forecast
10.5.2 South Africa Rapid Diagnostic Testing for Influenza Market Forecast
10.5.3 Israel Rapid Diagnostic Testing for Influenza Market Forecast
10.5.4 Turkey Rapid Diagnostic Testing for Influenza Market Forecast
10.5.5 GCC Countries Rapid Diagnostic Testing for Influenza Market Forecast
10.6 Global Rapid Diagnostic Testing for Influenza Forecast by Type (2024-2029)
10.7 Global Rapid Diagnostic Testing for Influenza Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Rapid Diagnostic Testing for Influenza Product Offered
11.1.3 BD Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 Abbot (Alere)
11.2.1 Abbot (Alere) Company Information
11.2.2 Abbot (Alere) Rapid Diagnostic Testing for Influenza Product Offered
11.2.3 Abbot (Alere) Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Abbot (Alere) Main Business Overview
11.2.5 Abbot (Alere) Latest Developments
11.3 Quidel
11.3.1 Quidel Company Information
11.3.2 Quidel Rapid Diagnostic Testing for Influenza Product Offered
11.3.3 Quidel Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Quidel Main Business Overview
11.3.5 Quidel Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Rapid Diagnostic Testing for Influenza Product Offered
11.4.3 Roche Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Information
11.5.2 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product Offered
11.5.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Thermo Fisher Scientific Main Business Overview
11.5.5 Thermo Fisher Scientific Latest Developments
11.6 Meridian Bioscience
11.6.1 Meridian Bioscience Company Information
11.6.2 Meridian Bioscience Rapid Diagnostic Testing for Influenza Product Offered
11.6.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Meridian Bioscience Main Business Overview
11.6.5 Meridian Bioscience Latest Developments
11.7 Analytik Jena
11.7.1 Analytik Jena Company Information
11.7.2 Analytik Jena Rapid Diagnostic Testing for Influenza Product Offered
11.7.3 Analytik Jena Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Analytik Jena Main Business Overview
11.7.5 Analytik Jena Latest Developments
11.8 Princeton BioMeditech Corporation
11.8.1 Princeton BioMeditech Corporation Company Information
11.8.2 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product Offered
11.8.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Princeton BioMeditech Corporation Main Business Overview
11.8.5 Princeton BioMeditech Corporation Latest Developments
11.9 BioMerieux
11.9.1 BioMerieux Company Information
11.9.2 BioMerieux Rapid Diagnostic Testing for Influenza Product Offered
11.9.3 BioMerieux Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 BioMerieux Main Business Overview
11.9.5 BioMerieux Latest Developments
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Information
11.10.2 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product Offered
11.10.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sekisui Diagnostics Main Business Overview
11.10.5 Sekisui Diagnostics Latest Developments
11.11 Response Biomedical
11.11.1 Response Biomedical Company Information
11.11.2 Response Biomedical Rapid Diagnostic Testing for Influenza Product Offered
11.11.3 Response Biomedical Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Response Biomedical Main Business Overview
11.11.5 Response Biomedical Latest Developments
11.12 SA Scientific
11.12.1 SA Scientific Company Information
11.12.2 SA Scientific Rapid Diagnostic Testing for Influenza Product Offered
11.12.3 SA Scientific Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 SA Scientific Main Business Overview
11.12.5 SA Scientific Latest Developments
11.13 DiaSorin (Focus Diagnostics)
11.13.1 DiaSorin (Focus Diagnostics) Company Information
11.13.2 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product Offered
11.13.3 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 DiaSorin (Focus Diagnostics) Main Business Overview
11.13.5 DiaSorin (Focus Diagnostics) Latest Developments
11.14 Wondfo
11.14.1 Wondfo Company Information
11.14.2 Wondfo Rapid Diagnostic Testing for Influenza Product Offered
11.14.3 Wondfo Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Wondfo Main Business Overview
11.14.5 Wondfo Latest Developments
11.15 Beijing Wantai Biological Pharmacy
11.15.1 Beijing Wantai Biological Pharmacy Company Information
11.15.2 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product Offered
11.15.3 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Beijing Wantai Biological Pharmacy Main Business Overview
11.15.5 Beijing Wantai Biological Pharmacy Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rapid Diagnostic Testing for Influenza Market Size 2018-2029
2.1.2 Rapid Diagnostic Testing for Influenza Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Rapid Diagnostic Testing for Influenza Segment by Type
2.2.1 Digital RIDTs
2.2.2 Conventional RIDT
2.3 Rapid Diagnostic Testing for Influenza Market Size by Type
2.3.1 Rapid Diagnostic Testing for Influenza Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
2.4 Rapid Diagnostic Testing for Influenza Segment by Application
2.4.1 Hospitals
2.4.2 POCT
2.4.3 Others
2.5 Rapid Diagnostic Testing for Influenza Market Size by Application
2.5.1 Rapid Diagnostic Testing for Influenza Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
3 RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET SIZE BY PLAYER
3.1 Rapid Diagnostic Testing for Influenza Market Size Market Share by Players
3.1.1 Global Rapid Diagnostic Testing for Influenza Revenue by Players (2018-2023)
3.1.2 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Players (2018-2023)
3.2 Global Rapid Diagnostic Testing for Influenza Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RAPID DIAGNOSTIC TESTING FOR INFLUENZA BY REGIONS
4.1 Rapid Diagnostic Testing for Influenza Market Size by Regions (2018-2023)
4.2 Americas Rapid Diagnostic Testing for Influenza Market Size Growth (2018-2023)
4.3 APAC Rapid Diagnostic Testing for Influenza Market Size Growth (2018-2023)
4.4 Europe Rapid Diagnostic Testing for Influenza Market Size Growth (2018-2023)
4.5 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Rapid Diagnostic Testing for Influenza Market Size by Country (2018-2023)
5.2 Americas Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023)
5.3 Americas Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rapid Diagnostic Testing for Influenza Market Size by Region (2018-2023)
6.2 APAC Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023)
6.3 APAC Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Rapid Diagnostic Testing for Influenza by Country (2018-2023)
7.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023)
7.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rapid Diagnostic Testing for Influenza by Region (2018-2023)
8.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023)
8.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RAPID DIAGNOSTIC TESTING FOR INFLUENZA MARKET FORECAST
10.1 Global Rapid Diagnostic Testing for Influenza Forecast by Regions (2024-2029)
10.1.1 Global Rapid Diagnostic Testing for Influenza Forecast by Regions (2024-2029)
10.1.2 Americas Rapid Diagnostic Testing for Influenza Forecast
10.1.3 APAC Rapid Diagnostic Testing for Influenza Forecast
10.1.4 Europe Rapid Diagnostic Testing for Influenza Forecast
10.1.5 Middle East & Africa Rapid Diagnostic Testing for Influenza Forecast
10.2 Americas Rapid Diagnostic Testing for Influenza Forecast by Country (2024-2029)
10.2.1 United States Rapid Diagnostic Testing for Influenza Market Forecast
10.2.2 Canada Rapid Diagnostic Testing for Influenza Market Forecast
10.2.3 Mexico Rapid Diagnostic Testing for Influenza Market Forecast
10.2.4 Brazil Rapid Diagnostic Testing for Influenza Market Forecast
10.3 APAC Rapid Diagnostic Testing for Influenza Forecast by Region (2024-2029)
10.3.1 China Rapid Diagnostic Testing for Influenza Market Forecast
10.3.2 Japan Rapid Diagnostic Testing for Influenza Market Forecast
10.3.3 Korea Rapid Diagnostic Testing for Influenza Market Forecast
10.3.4 Southeast Asia Rapid Diagnostic Testing for Influenza Market Forecast
10.3.5 India Rapid Diagnostic Testing for Influenza Market Forecast
10.3.6 Australia Rapid Diagnostic Testing for Influenza Market Forecast
10.4 Europe Rapid Diagnostic Testing for Influenza Forecast by Country (2024-2029)
10.4.1 Germany Rapid Diagnostic Testing for Influenza Market Forecast
10.4.2 France Rapid Diagnostic Testing for Influenza Market Forecast
10.4.3 UK Rapid Diagnostic Testing for Influenza Market Forecast
10.4.4 Italy Rapid Diagnostic Testing for Influenza Market Forecast
10.4.5 Russia Rapid Diagnostic Testing for Influenza Market Forecast
10.5 Middle East & Africa Rapid Diagnostic Testing for Influenza Forecast by Region (2024-2029)
10.5.1 Egypt Rapid Diagnostic Testing for Influenza Market Forecast
10.5.2 South Africa Rapid Diagnostic Testing for Influenza Market Forecast
10.5.3 Israel Rapid Diagnostic Testing for Influenza Market Forecast
10.5.4 Turkey Rapid Diagnostic Testing for Influenza Market Forecast
10.5.5 GCC Countries Rapid Diagnostic Testing for Influenza Market Forecast
10.6 Global Rapid Diagnostic Testing for Influenza Forecast by Type (2024-2029)
10.7 Global Rapid Diagnostic Testing for Influenza Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Rapid Diagnostic Testing for Influenza Product Offered
11.1.3 BD Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 Abbot (Alere)
11.2.1 Abbot (Alere) Company Information
11.2.2 Abbot (Alere) Rapid Diagnostic Testing for Influenza Product Offered
11.2.3 Abbot (Alere) Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Abbot (Alere) Main Business Overview
11.2.5 Abbot (Alere) Latest Developments
11.3 Quidel
11.3.1 Quidel Company Information
11.3.2 Quidel Rapid Diagnostic Testing for Influenza Product Offered
11.3.3 Quidel Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Quidel Main Business Overview
11.3.5 Quidel Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Rapid Diagnostic Testing for Influenza Product Offered
11.4.3 Roche Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Information
11.5.2 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product Offered
11.5.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Thermo Fisher Scientific Main Business Overview
11.5.5 Thermo Fisher Scientific Latest Developments
11.6 Meridian Bioscience
11.6.1 Meridian Bioscience Company Information
11.6.2 Meridian Bioscience Rapid Diagnostic Testing for Influenza Product Offered
11.6.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Meridian Bioscience Main Business Overview
11.6.5 Meridian Bioscience Latest Developments
11.7 Analytik Jena
11.7.1 Analytik Jena Company Information
11.7.2 Analytik Jena Rapid Diagnostic Testing for Influenza Product Offered
11.7.3 Analytik Jena Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Analytik Jena Main Business Overview
11.7.5 Analytik Jena Latest Developments
11.8 Princeton BioMeditech Corporation
11.8.1 Princeton BioMeditech Corporation Company Information
11.8.2 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product Offered
11.8.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Princeton BioMeditech Corporation Main Business Overview
11.8.5 Princeton BioMeditech Corporation Latest Developments
11.9 BioMerieux
11.9.1 BioMerieux Company Information
11.9.2 BioMerieux Rapid Diagnostic Testing for Influenza Product Offered
11.9.3 BioMerieux Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 BioMerieux Main Business Overview
11.9.5 BioMerieux Latest Developments
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Information
11.10.2 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product Offered
11.10.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sekisui Diagnostics Main Business Overview
11.10.5 Sekisui Diagnostics Latest Developments
11.11 Response Biomedical
11.11.1 Response Biomedical Company Information
11.11.2 Response Biomedical Rapid Diagnostic Testing for Influenza Product Offered
11.11.3 Response Biomedical Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Response Biomedical Main Business Overview
11.11.5 Response Biomedical Latest Developments
11.12 SA Scientific
11.12.1 SA Scientific Company Information
11.12.2 SA Scientific Rapid Diagnostic Testing for Influenza Product Offered
11.12.3 SA Scientific Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 SA Scientific Main Business Overview
11.12.5 SA Scientific Latest Developments
11.13 DiaSorin (Focus Diagnostics)
11.13.1 DiaSorin (Focus Diagnostics) Company Information
11.13.2 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product Offered
11.13.3 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 DiaSorin (Focus Diagnostics) Main Business Overview
11.13.5 DiaSorin (Focus Diagnostics) Latest Developments
11.14 Wondfo
11.14.1 Wondfo Company Information
11.14.2 Wondfo Rapid Diagnostic Testing for Influenza Product Offered
11.14.3 Wondfo Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Wondfo Main Business Overview
11.14.5 Wondfo Latest Developments
11.15 Beijing Wantai Biological Pharmacy
11.15.1 Beijing Wantai Biological Pharmacy Company Information
11.15.2 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product Offered
11.15.3 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Beijing Wantai Biological Pharmacy Main Business Overview
11.15.5 Beijing Wantai Biological Pharmacy Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Rapid Diagnostic Testing for Influenza Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Digital RIDTs
Table 3. Major Players of Conventional RIDT
Table 4. Rapid Diagnostic Testing for Influenza Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
Table 7. Rapid Diagnostic Testing for Influenza Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
Table 10. Global Rapid Diagnostic Testing for Influenza Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Player (2018-2023)
Table 12. Rapid Diagnostic Testing for Influenza Key Players Head office and Products Offered
Table 13. Rapid Diagnostic Testing for Influenza Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Rapid Diagnostic Testing for Influenza Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Regions (2018-2023)
Table 18. Global Rapid Diagnostic Testing for Influenza Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Rapid Diagnostic Testing for Influenza Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Rapid Diagnostic Testing for Influenza Market Size Market Share by Country (2018-2023)
Table 22. Americas Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
Table 24. Americas Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
Table 26. APAC Rapid Diagnostic Testing for Influenza Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Region (2018-2023)
Table 28. APAC Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
Table 30. APAC Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
Table 32. Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Country (2018-2023)
Table 34. Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
Table 36. Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Rapid Diagnostic Testing for Influenza
Table 45. Key Market Challenges & Risks of Rapid Diagnostic Testing for Influenza
Table 46. Key Industry Trends of Rapid Diagnostic Testing for Influenza
Table 47. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Rapid Diagnostic Testing for Influenza Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. BD Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 52. BD Rapid Diagnostic Testing for Influenza Product Offered
Table 53. BD Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. BD Main Business
Table 55. BD Latest Developments
Table 56. Abbot (Alere) Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 57. Abbot (Alere) Rapid Diagnostic Testing for Influenza Product Offered
Table 58. Abbot (Alere) Main Business
Table 59. Abbot (Alere) Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Abbot (Alere) Latest Developments
Table 61. Quidel Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 62. Quidel Rapid Diagnostic Testing for Influenza Product Offered
Table 63. Quidel Main Business
Table 64. Quidel Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Quidel Latest Developments
Table 66. Roche Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 67. Roche Rapid Diagnostic Testing for Influenza Product Offered
Table 68. Roche Main Business
Table 69. Roche Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Roche Latest Developments
Table 71. Thermo Fisher Scientific Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 72. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product Offered
Table 73. Thermo Fisher Scientific Main Business
Table 74. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Thermo Fisher Scientific Latest Developments
Table 76. Meridian Bioscience Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 77. Meridian Bioscience Rapid Diagnostic Testing for Influenza Product Offered
Table 78. Meridian Bioscience Main Business
Table 79. Meridian Bioscience Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Meridian Bioscience Latest Developments
Table 81. Analytik Jena Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 82. Analytik Jena Rapid Diagnostic Testing for Influenza Product Offered
Table 83. Analytik Jena Main Business
Table 84. Analytik Jena Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Analytik Jena Latest Developments
Table 86. Princeton BioMeditech Corporation Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 87. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product Offered
Table 88. Princeton BioMeditech Corporation Main Business
Table 89. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Princeton BioMeditech Corporation Latest Developments
Table 91. BioMerieux Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 92. BioMerieux Rapid Diagnostic Testing for Influenza Product Offered
Table 93. BioMerieux Main Business
Table 94. BioMerieux Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. BioMerieux Latest Developments
Table 96. Sekisui Diagnostics Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 97. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product Offered
Table 98. Sekisui Diagnostics Main Business
Table 99. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Sekisui Diagnostics Latest Developments
Table 101. Response Biomedical Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 102. Response Biomedical Rapid Diagnostic Testing for Influenza Product Offered
Table 103. Response Biomedical Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Response Biomedical Main Business
Table 105. Response Biomedical Latest Developments
Table 106. SA Scientific Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 107. SA Scientific Rapid Diagnostic Testing for Influenza Product Offered
Table 108. SA Scientific Main Business
Table 109. SA Scientific Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. SA Scientific Latest Developments
Table 111. DiaSorin (Focus Diagnostics) Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 112. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product Offered
Table 113. DiaSorin (Focus Diagnostics) Main Business
Table 114. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. DiaSorin (Focus Diagnostics) Latest Developments
Table 116. Wondfo Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 117. Wondfo Rapid Diagnostic Testing for Influenza Product Offered
Table 118. Wondfo Main Business
Table 119. Wondfo Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Wondfo Latest Developments
Table 121. Beijing Wantai Biological Pharmacy Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 122. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product Offered
Table 123. Beijing Wantai Biological Pharmacy Main Business
Table 124. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Beijing Wantai Biological Pharmacy Latest Developments
Table 1. Rapid Diagnostic Testing for Influenza Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Digital RIDTs
Table 3. Major Players of Conventional RIDT
Table 4. Rapid Diagnostic Testing for Influenza Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
Table 7. Rapid Diagnostic Testing for Influenza Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
Table 10. Global Rapid Diagnostic Testing for Influenza Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Player (2018-2023)
Table 12. Rapid Diagnostic Testing for Influenza Key Players Head office and Products Offered
Table 13. Rapid Diagnostic Testing for Influenza Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Rapid Diagnostic Testing for Influenza Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Regions (2018-2023)
Table 18. Global Rapid Diagnostic Testing for Influenza Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Rapid Diagnostic Testing for Influenza Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Rapid Diagnostic Testing for Influenza Market Size Market Share by Country (2018-2023)
Table 22. Americas Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
Table 24. Americas Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
Table 26. APAC Rapid Diagnostic Testing for Influenza Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Region (2018-2023)
Table 28. APAC Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
Table 30. APAC Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
Table 32. Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Country (2018-2023)
Table 34. Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
Table 36. Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Rapid Diagnostic Testing for Influenza
Table 45. Key Market Challenges & Risks of Rapid Diagnostic Testing for Influenza
Table 46. Key Industry Trends of Rapid Diagnostic Testing for Influenza
Table 47. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Rapid Diagnostic Testing for Influenza Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. BD Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 52. BD Rapid Diagnostic Testing for Influenza Product Offered
Table 53. BD Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. BD Main Business
Table 55. BD Latest Developments
Table 56. Abbot (Alere) Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 57. Abbot (Alere) Rapid Diagnostic Testing for Influenza Product Offered
Table 58. Abbot (Alere) Main Business
Table 59. Abbot (Alere) Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Abbot (Alere) Latest Developments
Table 61. Quidel Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 62. Quidel Rapid Diagnostic Testing for Influenza Product Offered
Table 63. Quidel Main Business
Table 64. Quidel Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Quidel Latest Developments
Table 66. Roche Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 67. Roche Rapid Diagnostic Testing for Influenza Product Offered
Table 68. Roche Main Business
Table 69. Roche Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Roche Latest Developments
Table 71. Thermo Fisher Scientific Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 72. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product Offered
Table 73. Thermo Fisher Scientific Main Business
Table 74. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Thermo Fisher Scientific Latest Developments
Table 76. Meridian Bioscience Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 77. Meridian Bioscience Rapid Diagnostic Testing for Influenza Product Offered
Table 78. Meridian Bioscience Main Business
Table 79. Meridian Bioscience Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Meridian Bioscience Latest Developments
Table 81. Analytik Jena Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 82. Analytik Jena Rapid Diagnostic Testing for Influenza Product Offered
Table 83. Analytik Jena Main Business
Table 84. Analytik Jena Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Analytik Jena Latest Developments
Table 86. Princeton BioMeditech Corporation Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 87. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product Offered
Table 88. Princeton BioMeditech Corporation Main Business
Table 89. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Princeton BioMeditech Corporation Latest Developments
Table 91. BioMerieux Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 92. BioMerieux Rapid Diagnostic Testing for Influenza Product Offered
Table 93. BioMerieux Main Business
Table 94. BioMerieux Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. BioMerieux Latest Developments
Table 96. Sekisui Diagnostics Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 97. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product Offered
Table 98. Sekisui Diagnostics Main Business
Table 99. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Sekisui Diagnostics Latest Developments
Table 101. Response Biomedical Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 102. Response Biomedical Rapid Diagnostic Testing for Influenza Product Offered
Table 103. Response Biomedical Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Response Biomedical Main Business
Table 105. Response Biomedical Latest Developments
Table 106. SA Scientific Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 107. SA Scientific Rapid Diagnostic Testing for Influenza Product Offered
Table 108. SA Scientific Main Business
Table 109. SA Scientific Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. SA Scientific Latest Developments
Table 111. DiaSorin (Focus Diagnostics) Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 112. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product Offered
Table 113. DiaSorin (Focus Diagnostics) Main Business
Table 114. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. DiaSorin (Focus Diagnostics) Latest Developments
Table 116. Wondfo Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 117. Wondfo Rapid Diagnostic Testing for Influenza Product Offered
Table 118. Wondfo Main Business
Table 119. Wondfo Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Wondfo Latest Developments
Table 121. Beijing Wantai Biological Pharmacy Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors
Table 122. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product Offered
Table 123. Beijing Wantai Biological Pharmacy Main Business
Table 124. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Beijing Wantai Biological Pharmacy Latest Developments
LIST OF FIGURES
Figure 1. Rapid Diagnostic Testing for Influenza Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rapid Diagnostic Testing for Influenza Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Rapid Diagnostic Testing for Influenza Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Rapid Diagnostic Testing for Influenza Sales Market Share by Country/Region (2022)
Figure 8. Rapid Diagnostic Testing for Influenza Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Type in 2022
Figure 10. Rapid Diagnostic Testing for Influenza in Hospitals
Figure 11. Global Rapid Diagnostic Testing for Influenza Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Rapid Diagnostic Testing for Influenza in POCT
Figure 13. Global Rapid Diagnostic Testing for Influenza Market: POCT (2018-2023) & ($ Millions)
Figure 14. Rapid Diagnostic Testing for Influenza in Others
Figure 15. Global Rapid Diagnostic Testing for Influenza Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Application in 2022
Figure 17. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Player in 2022
Figure 18. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Rapid Diagnostic Testing for Influenza Market Size 2018-2023 ($ Millions)
Figure 20. APAC Rapid Diagnostic Testing for Influenza Market Size 2018-2023 ($ Millions)
Figure 21. Europe Rapid Diagnostic Testing for Influenza Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size 2018-2023 ($ Millions)
Figure 23. Americas Rapid Diagnostic Testing for Influenza Value Market Share by Country in 2022
Figure 24. United States Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Region in 2022
Figure 29. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Type in 2022
Figure 30. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Application in 2022
Figure 31. China Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Country in 2022
Figure 38. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
Figure 39. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
Figure 40. Germany Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 54. APAC Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 55. Europe Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 57. United States Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 58. Canada Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 61. China Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 62. Japan Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 63. Korea Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 65. India Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 66. Australia Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 67. Germany Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 68. France Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 69. UK Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 70. Italy Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 71. Russia Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 72. Spain Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 75. Israel Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 78. Global Rapid Diagnostic Testing for Influenza Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Rapid Diagnostic Testing for Influenza Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Rapid Diagnostic Testing for Influenza Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rapid Diagnostic Testing for Influenza Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Rapid Diagnostic Testing for Influenza Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Rapid Diagnostic Testing for Influenza Sales Market Share by Country/Region (2022)
Figure 8. Rapid Diagnostic Testing for Influenza Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Type in 2022
Figure 10. Rapid Diagnostic Testing for Influenza in Hospitals
Figure 11. Global Rapid Diagnostic Testing for Influenza Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Rapid Diagnostic Testing for Influenza in POCT
Figure 13. Global Rapid Diagnostic Testing for Influenza Market: POCT (2018-2023) & ($ Millions)
Figure 14. Rapid Diagnostic Testing for Influenza in Others
Figure 15. Global Rapid Diagnostic Testing for Influenza Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Application in 2022
Figure 17. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Player in 2022
Figure 18. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Rapid Diagnostic Testing for Influenza Market Size 2018-2023 ($ Millions)
Figure 20. APAC Rapid Diagnostic Testing for Influenza Market Size 2018-2023 ($ Millions)
Figure 21. Europe Rapid Diagnostic Testing for Influenza Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size 2018-2023 ($ Millions)
Figure 23. Americas Rapid Diagnostic Testing for Influenza Value Market Share by Country in 2022
Figure 24. United States Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Region in 2022
Figure 29. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Type in 2022
Figure 30. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Application in 2022
Figure 31. China Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Country in 2022
Figure 38. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
Figure 39. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
Figure 40. Germany Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Rapid Diagnostic Testing for Influenza Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 54. APAC Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 55. Europe Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 57. United States Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 58. Canada Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 61. China Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 62. Japan Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 63. Korea Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 65. India Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 66. Australia Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 67. Germany Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 68. France Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 69. UK Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 70. Italy Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 71. Russia Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 72. Spain Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 75. Israel Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Rapid Diagnostic Testing for Influenza Market Size 2024-2029 ($ Millions)
Figure 78. Global Rapid Diagnostic Testing for Influenza Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Rapid Diagnostic Testing for Influenza Market Size Market Share Forecast by Application (2024-2029)
